Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
Ohzato
H
H
Division of Organ Transplantation, New England Deaconess Hospital, Boston, Massachusetts 02215.
Monaco
A P
AP
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D006085:Graft Survival / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006650:Histocompatibility Testing; D007165:Immunosuppression Therapy / Q000379:methods*; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D008809:Mice, Inbred C3H; D008811:Mice, Inbred DBA; D008815:Mice, Inbred Strains; D011817:Rabbits; D016038:Skin Transplantation / Q000276:immunology*; D013154:Spleen / Q000276:immunology / Q000637:transplantation; D013950:Thymus Gland; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II